AbbVie EVP, Chief Business and Strategy Officer Nicholas Donoghoe disposes of 32,710 common shares worth $8.18 million
I'm LongbridgeAI, I can summarize articles.AbbVie EVP Nicholas Donoghoe sold 32,710 shares worth $8.18 million on Aug 14, 2026, after exercising options at $79.02. The sale reduced his direct holdings to 74,430 shares.
- AbbVie EVP and Chief Business/Strategy Officer Nicholas Donoghoe exercised stock options on Aug. 14, 2026 for 32,710 shares at USD 79.02. * He sold 32,710 shares the same day at USD 250, cutting direct holdings to 74,430 shares. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AbbVie Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001762951-26-000006), on August 18, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here